Ken Taylor is the Chief Executive Officer of Living Cell Technologies Ltd. He completed a postdoctoral fellowship in Pharmacology and Experimental Therapeutics at the Johns Hopkins University School of Medicine in Baltimore, Maryland and subsequently held a joint appointment in neurosciences at Princeton University and the Squibb Institute of Medical research in Princeton, New Jersey.
Born and educated in New Zealand, Dr. Taylor earned honors and doctorate degrees in pharmaceutical chemistry and pharmacology from the University of Otago School of Medicine. Additionally, in 1986, he completed a business management program at IMD in Lausanne, Switzerland.
In 1975 he joined Roche to establish a pharmacology research and clinical pharmacology program in Sydney, Australia and later was appointed Medical Director then Managing Director for Roche in New Zealand. In 1990, he was appointed Managing Director of the Roche UK affiliate and then transferred to Syntex in Palo Alto, California to convert the corporate pharmaceutical company to Roche Bioscience, a research center. He later returned to New Zealand to manage the Roche affiliate and also to help Roche find research alliances in the Asia Pacific area.
Dr. Taylor is an Adjunct Professor of Pharmacy at the University of Otago, Dunedin, pharmaceutical development and biotechnology consultant at the University of Auckland, New Zealand and was a director of the Foundation for Research, Science and Technology, the New Zealand government's agency for funding scientific research.